AB0732 OUTCOMES OF PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY IN TAKAYASU ARTERITIS: A SINGLE CENTER EXPERIENCE

Background Revascularization endovascular techniques have been used with success in Takayasu arteritis (TA), but relapses sometimes appear. (1) There is much debate regarding optimal management and outcomes of patients who underwent these procedures. (2,3) Objectives The aim the study was to investigate long-term efficacy percutaneous transluminal angioplasty (PTA) TA from a Romanian tertiary rheumatology center factors that might influence it. Methods Data clinical charts diagnosis established last 15 years interventional revascularization procedures were retrospectively studied. Symptoms, laboratory investigation results, data about treatment outcome analyzed at baseline follow-up. Results 11 interventions PTA 6 TAK, all them women. mean follow-up period 59 months. Cardiologists ones diagnosed disease 83% included. delay 74 months, while biggest 242 Hypertension first sign 3 patients, rest complained limb claudication (2 patients) acute ischemia phenomenon (1 patient). average duration until 65 months most done time (54%). performed active 100% cases biological inflammatory syndrome present 45% cases. Symptoms relief seen patients. Restenosis – two lack adherence one patient wasn’t given immunosuppression (due diagnosis). experienced 52 after PTA, on average. included relapse 2 hypertension renal failure artery restenosis. Inflammatory markers raised Clinical improvement reintervention. Conclusion valuable intervention significantly improves symptoms. Relapses may appear especially deficient immunosuppression, they need interventions. References [1]Diao Y, Yan S, Premaratne Chen Tian X, Z et al. Surgery Endovascular Management Patients With Takayasu’s Arteritis: A Ten-Year Retrospective Study. Ann Vasc Surg. 2020; 63:34-44. [2]Jung JH, Lee YH, Song GG, Jeong HS, Kim Choi SJ. Versus Open Surgical Intervention Meta-analysis. Eur J Endovasc 2018; 55(6):888-99. [3]Perera AH, Youngstein T, Gibbs RG, Jackson JE, Wolfe Mason JC. Optimizing vascular for arteritis. Br 2014; 101(2):43-50. Acknowledgements: NIL. Disclosure Interests None Declared.